These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Association of heart structure and function abnormalities with laboratory findings in patients with systemic lupus erythematosus. Plazak W, Gryga K, Milewski M, Podolec M, Kostkiewicz M, Podolec P, Musial J. Lupus; 2011 Aug; 20(9):936-44. PubMed ID: 21636627 [Abstract] [Full Text] [Related]
8. Anti-BB'-Sm antibodies, anticardiolipin antibodies, and thrombosis in systemic lupus erythematosus. López-Longo FJ, Monteagudo I, González CM, Moreno AC, Rodríguez Mahou M, Grau R, Carreño L. J Rheumatol; 1998 Sep; 25(9):1743-9. PubMed ID: 9733455 [Abstract] [Full Text] [Related]
9. Relationship of antiphospholipid antibodies to cardiovascular manifestations of systemic lupus erythematosus. Farzaneh-Far A, Roman MJ, Lockshin MD, Devereux RB, Paget SA, Crow MK, Davis A, Sammaritano L, Levine DM, Salmon JE. Arthritis Rheum; 2006 Dec; 54(12):3918-25. PubMed ID: 17133599 [Abstract] [Full Text] [Related]
10. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Hanly JG, Hong C, Smith S, Fisk JD. Arthritis Rheum; 1999 Apr; 42(4):728-34. PubMed ID: 10211887 [Abstract] [Full Text] [Related]
11. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus. Nojima J, Masuda Y, Iwatani Y, Kuratsune H, Watanabe Y, Suehisa E, Takano T, Hidaka Y, Kanakura Y. Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400 [Abstract] [Full Text] [Related]
12. Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus. Molina JF, Gutierrez-Ureña S, Molina J, Uribe O, Richards S, De Ceulaer C, Garcia C, Wilson WA, Gharavi AE, Espinoza LR. J Rheumatol; 1997 Feb; 24(2):291-6. PubMed ID: 9034985 [Abstract] [Full Text] [Related]
13. Cardiac valvular disease in patients with systemic lupus erythematosus. Relationship with anticardiolipin antibodies. Leszczyński P, Straburzyńska-Migaj E, Korczowska I, Łacki JK, Mackiewicz S. Clin Rheumatol; 2003 Dec; 22(6):405-8. PubMed ID: 14677016 [Abstract] [Full Text] [Related]
16. Anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus. Prevalence and clinical associations. European Concerted Action on the Immunogenetics of SLE. Sebastiani GD, Galeazzi M, Tincani A, Piette JC, Font J, Allegri F, Mathieu A, Smolen J, de Ramon Garrido E, Fernandez-Nebro A, Jedryka-Goral A, Papasteriades C, Morozzi G, Bellisai F, De Pitá O, Marcolongo R. Scand J Rheumatol; 1999 Dec; 28(6):344-51. PubMed ID: 10665739 [Abstract] [Full Text] [Related]
17. Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study. Perez-Villa F, Font J, Azqueta M, Espinosa G, Pare C, Cervera R, Reverter JC, Ingelmo M, Sanz G. Arthritis Rheum; 2005 Jun 15; 53(3):460-7. PubMed ID: 15934103 [Abstract] [Full Text] [Related]
18. Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors. Afeltra A, Vadacca M, Conti L, Galluzzo S, Mitterhofer AP, Ferri GM, Del Porto F, Caccavo D, Gandolfo GM, Amoroso A. Arthritis Rheum; 2005 Jun 15; 53(3):452-9. PubMed ID: 15934123 [Abstract] [Full Text] [Related]